Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the initiation of a Phase 2 ...

In an article published online Dec. 3 in European Radiology, the authors explore the performance and optimal combination of MRI.

A new study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

Deeptech neuroscience startup BrainSightAI has secured $5 Mn (around INR 43 Cr) in a Pre-Series A funding round led by IAN ...

Gilas Pilipinas is keeping its fingers crossed as the team awaits the result of Kai Sotto's magnetic resonance imaging (MRI) ...

The human brain undergoes significant changes over time, with its functional and structural dynamics evolving as we age.

A recent study from the McGovern Institute for Brain Research shows how interests can modulate language processing in ...

Topline data from Phase 3 REFOCUS-ALZ study of simufilam in patients with mild-to-moderate Alzheimer’s disease expected late first-quarter/early ...

Researchers at UT Southwestern Medical Center have discovered sex-specific differences in how fat accumulates in muscle and ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

Discover groundbreaking research on brain development and sex differences in infants. Explore how structural brain differences are already established at birth.

Bioxytran presented four key Areas of Interest (AOI): an influenza antiviral, immune modulators for lung repair, solutions for uncontrolled hemorrhaging, and a versatile strategic therapeutic. The ...